ZTS vs. BMY, PFE, ABBV, GSK, REGN, VRTX, TAK, SNY, GMAB, and ALNY
Should you be buying Zoetis stock or one of its competitors? The main competitors of Zoetis include Bristol-Myers Squibb (BMY), Pfizer (PFE), AbbVie (ABBV), GSK (GSK), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Takeda Pharmaceutical (TAK), Sanofi (SNY), Genmab A/S (GMAB), and Alnylam Pharmaceuticals (ALNY). These companies are all part of the "pharmaceutical preparations" industry.
Bristol-Myers Squibb (NYSE:BMY) and Zoetis (NYSE:ZTS) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, community ranking, valuation, earnings, dividends and media sentiment.
76.4% of Bristol-Myers Squibb shares are owned by institutional investors. Comparatively, 92.8% of Zoetis shares are owned by institutional investors. 0.1% of Bristol-Myers Squibb shares are owned by company insiders. Comparatively, 0.2% of Zoetis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Bristol-Myers Squibb has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, Zoetis has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500.
Bristol-Myers Squibb currently has a consensus price target of $61.12, indicating a potential upside of 25.14%. Zoetis has a consensus price target of $224.88, indicating a potential upside of 47.33%. Given Bristol-Myers Squibb's stronger consensus rating and higher possible upside, analysts clearly believe Zoetis is more favorable than Bristol-Myers Squibb.
Zoetis has a net margin of 27.43% compared to Zoetis' net margin of 17.83%. Bristol-Myers Squibb's return on equity of 51.25% beat Zoetis' return on equity.
Bristol-Myers Squibb pays an annual dividend of $2.40 per share and has a dividend yield of 4.9%. Zoetis pays an annual dividend of $1.73 per share and has a dividend yield of 1.1%. Bristol-Myers Squibb pays out 62.2% of its earnings in the form of a dividend. Zoetis pays out 34.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Zoetis has increased its dividend for 12 consecutive years.
Bristol-Myers Squibb received 184 more outperform votes than Zoetis when rated by MarketBeat users. However, 77.72% of users gave Zoetis an outperform vote while only 66.98% of users gave Bristol-Myers Squibb an outperform vote.
Bristol-Myers Squibb has higher revenue and earnings than Zoetis. Bristol-Myers Squibb is trading at a lower price-to-earnings ratio than Zoetis, indicating that it is currently the more affordable of the two stocks.
In the previous week, Zoetis had 7 more articles in the media than Bristol-Myers Squibb. MarketBeat recorded 47 mentions for Zoetis and 40 mentions for Bristol-Myers Squibb. Zoetis' average media sentiment score of 0.77 beat Bristol-Myers Squibb's score of 0.12 indicating that Bristol-Myers Squibb is being referred to more favorably in the media.
Summary
Zoetis beats Bristol-Myers Squibb on 16 of the 21 factors compared between the two stocks.
Get Zoetis News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ZTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
